Adjunctive aripiprazole for antipsychotic-related hyperprolactinaemia in patients with first-episode schizophrenia: a meta-analysis

BACKGROUND: Hyperprolactinaemia is a common antipsychotic (AP)-induced adverse effect, particularly in female patients. AIMS: This meta-analysis examined the efficacy and safety of adjunctive aripiprazole in preventing AP-related hyperprolactinaemia in patients with first-episode schizophrenia. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Wei, Cai, Dong-Bin, Yang, Xin-Hu, Ungvari, Gabor S, Ng, Chee H, Shi, Zhan-Ming, Hu, Mei-Ling, Ning, Yu-Ping, Xiang, Yu-Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802974/
https://www.ncbi.nlm.nih.gov/pubmed/31673677
http://dx.doi.org/10.1136/gpsych-2019-100091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802974/
https://www.ncbi.nlm.nih.gov/pubmed/31673677
http://dx.doi.org/10.1136/gpsych-2019-100091

Ejemplares similares